| 发明名称 |
Histone deacetylase (hdac) inhibitors (pxd-101) alone for the treatment of hematological cancer |
| 摘要 |
<p>The present invention relates generally to certain histone deacetylase (HDAC) inhibitors, as described and including, for example, PXD-101, for treatment of a hematological cancer selected from multiple myeloma, leukemia, and lymphoma.</p> |
| 申请公布号 |
EP2361619(A1) |
申请公布日期 |
2011.08.31 |
| 申请号 |
EP20110003902 |
申请日期 |
2006.11.10 |
| 申请人 |
TOPOTARGET UK LIMITED |
发明人 |
LICHTENSTEIN, HENRI;EDWARDS, NICHOLAS;RITCHIE, JAMES;PETERSEN, KAMILLE DUMONG;PLUMB, JANE |
| 分类号 |
A61K31/10;A61P35/00 |
主分类号 |
A61K31/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
